Tasly Pharmaceutical Group announced that its wholly-owned subsidiary, Jiangsu Diyi's levocetirizine dihydrochloride tablets have passed the quality and efficacy consistency evaluation of generic drugs. This pharmaceutical is used for allergic rhinitis and allergic asthma.
天士力：子公司药品通过仿制药一致性评价
Tasly Pharmaceutical Group: Subsidiary pharmaceuticals pass generic drug consistency evaluation.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.